Showing results (191-200 of 213) with videos related to
Sort By:
Pageof 22
Current Microbiology|July 12, 2012
Detection of virulence factors and molecular typing of pathogenic Leptospira from capybara (Hydrochaeris hydrochaeris)Sérgio Jorge, Leonardo G Monte, Marco Antonio Coimbra, et al.Current Microbiology|June 24, 2015
Phenotypic and Molecular Characterization of Leptospira interrogans Isolated from Canis familiaris in Southern BrazilSérgio Jorge, Leonardo G Monte, Natasha R De Oliveira, et al.Health Technology Assessment (Winchester, England)|April 1, 2014
A randomised controlled trial of the clinical effectiveness and cost-effectiveness of different knee prostheses: the Knee Arthroplasty Trial (KAT)David W Murray, Graeme S MacLennan, Suzanne Breeman, et al.The Journal of Thoracic and Cardiovascular Surgery|July 7, 2009
Uric acid levels and outcome from coronary artery bypass graftingGraham S Hillis, Brian H Cuthbertson, Patrick H Gibson, et al.Clinical and Vaccine Immunology : CVI|October 28, 2011
Subunit approach to evaluation of the immune protective potential of leptospiral antigensSamuel R Félix, Daiane D Hartwig, Ana Paula C Argondizzo, et al.Biomed Research International|June 5, 2014
Xanthan gum as an adjuvant in a subunit vaccine preparation against leptospirosisKatia L Bacelo, Daiane D Hartwig, Fabiana K Seixas, et al.Memorias Do Instituto Oswaldo Cruz|October 21, 2016
Immune response in hamsters immunised with a recombinant fragment of LigA from Leptospira interrogans, associated with carrier moleculesThaís L Oliveira, Kátia L Bacelo, Rodrigo A Schuch, et al.Current Microbiology|December 18, 2013
Mannosylated LigANI produced in Pichia pastoris protects hamsters against leptospirosisDaiane D Hartwig, Kátia L Bacelo, Patrícia D de Oliveira, et al.Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|October 26, 2013
Characterization of a virulent Leptospira interrogans strain isolated from an abandoned swimming poolKarine M Forster, Daiane D Hartwig, Fabiana K Seixas, et al.Vox Sanguinis|January 15, 2016
Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodiesC Geisen, G Kann, T Strecker, et al.Pageof 22